Congratulations to 4D pharma plc on their business combination with Longevity Acquisition Corporation and listing on Nasdaq.
Completion of Merger with Longevity Acquisition Corporation and admission of American Depositary Shares to trading on NASDAQ Merck Sharp & Dohme to participate in previously announced private placement Gross proceeds of Merger and private placement total approximately $39.8 million Leeds, UK – 22 March 2021 – 4D pharma plc (AIM: DDDD) (“4D” or the […]
Congratulations to Chemomab Therapeutics Ltd. on its closing of the combination transaction and listing on Nasdaq!
Chemomab Completes Merger with Anchiano Therapeutics Shares of Chemomab Therapeutics to commence trading on the Nasdaq Capital Market on March 17, 2021 under the new ticker symbol “CMMB” Combined company will focus on advancing Chemomab’s CM-101 currently in Phase 2 for rare fibrotic indications Company to receive gross proceeds of $45.5 Million from a PIPE […]
Virtual 33rd Annual Roth Conference: Dave Donohoe, Roadmap to Uplisting – When, Where and How?
https://wsw.com/webcast/roth35/panel27/2115261
